SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells

Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma

(2017) Y Idoux-Gillet et al.   ONCOGENE

Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells

(2016) A. S. Ribeiro et al.   Nanoscale

Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip

(2016) Anna Herland et al.   PLoS One

P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells

(2015) André Filipe Vieira et al.   Oncotarget

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype

(2014) Bárbara Sousa et al.   BMC CANCER

Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants

(2014) João Miguel Sanches et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Targeting TBP-Associated Factors in Ovarian Cancer

(2014) Jennifer R. Ribeiro et al.   Frontiers in Oncology

Molecularly targeted therapies for metastatic triple-negative breast cancer

(2013) Soley Bayraktar et al.   BREAST CANCER RESEARCH AND TREATMENT

Dasatinib plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy in Phase I Study CA180004

(2013) G. Somlo et al.   CLINICAL CANCER RESEARCH

E-cadherin-integrin crosstalk in cancer invasion and metastasis

(2013) M. Canel et al.   JOURNAL OF CELL SCIENCE

The Bacterial Protein Azurin Impairs Invasion and FAK/Src Signaling in P-Cadherin-Overexpressing Breast Cancer Cell Models

(2013) Nuno Bernardes et al.   PLoS One

P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model

(2012) Ana Sofia Ribeiro et al.   JOURNAL OF PATHOLOGY

P-Cadherin Is Coexpressed with CD44 and CD49f and Mediates Stem Cell Properties in Basal-like Breast Cancer

(2012) André Filipe Vieira et al.   STEM CELLS

Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing

(2011) Christina I. Herold et al.   CLINICAL CANCER RESEARCH

Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement

(2011) Alan Serrels et al.   Cell Adhesion & Migration

Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma

(2010) Jennifer P. Morton et al.   GASTROENTEROLOGY

An essential role for p120-catenin in Src- and Rac1-mediated anchorage-independent cell growth

(2009) Michael R. Dohn et al.   JOURNAL OF CELL BIOLOGY

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells

(2009) A S Ribeiro et al.   ONCOGENE

Clinical significance of basal-like subtype in triple-negative breast cancer

(2009) Yutaka Yamamoto et al.   Breast Cancer

Targeting Src in breast cancer

(2008) R. S. Finn   ANNALS OF ONCOLOGY

Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival

(2008) J Paredes et al.   JOURNAL OF CLINICAL PATHOLOGY

Triple-negative/basal-like breast cancer: review

(2008) Emad A. Rakha et al.   PATHOLOGY